In other recent news, ModivCare Inc. has experienced a series of significant developments. S&P Global Ratings recently downgraded ModivCare's issuer credit rating to 'CCC+' due to ongoing collection difficulties and the withdrawal of its 2024 and 2025 guidance. The company has announced plans to issue a $75 million first-lien term loan to improve liquidity and is considering asset divestitures to repay debt. Jefferies has also adjusted ModivCare's stock price target to $5.25 from $18, maintaining a Hold rating, following the company's reduced fiscal year 2024 guidance. Additionally, Lake Street Capital Markets has lowered its price target for ModivCare shares to $10.00, down from $30.00, but continues to rate the stock as a Buy.